VERNIERI, CLAUDIO

VERNIERI, CLAUDIO  

Universita' degli Studi di MILANO  

Risultati 1 - 20 di 28 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study 1-set-2017 C. VernieriA. MennittoF. de Braud + Article (author) -
Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders 1-mag-2020 Vernieri C.Foiani M. + Article (author) -
Cells Escape an Operational Mitotic Checkpoint through a Stochastic Process 1-gen-2018 Bonaiuti, PaoloGross, FridolinCorno, AndreaVernieri, ClaudioCosentino Lagomarsino, Marco + Article (author) -
Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies 1-feb-2019 Randon G.Vernieri C.de Braud F. + Article (author) -
Diet and supplements in cancer prevention and treatment : clinical evidences and future perspectives 1-mar-2018 C. VernieriF. NichettiA. RaimondiF. de Braud + Article (author) -
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 25-lug-2017 Vernieri, ClaudioVolpi, Chiara CostanzaNiger, MonicaValtorta, EmanueleFucà, GiovanniDi Bartolomeo, MariaDe Braud, FilippoPietrantonio, Filippo + Article (author) -
Endosomal trafficking and DNA damage checkpoint kinases dictate survival to replication stress by regulating amino acid uptake and protein synthesis 27-set-2021 Ajazi A.Manfrini N.Biffo S.Minucci S.Vernieri C.Foiani M. + Article (author) -
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma : the FAME Trial 1-gen-2019 Vernieri, ClaudioGalli, GiuliaRizzo, Angela MariaCorsetto, Paola AntoniaPruneri, Giancarlode Braud, Filippo + Article (author) -
Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer 1-mag-2017 F. PietrantonioC. VernieriA. MennittoF. De Braud + Article (author) -
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies 1-apr-2016 S. PuscedduF. De BraudC. VernieriA. Indini + Article (author) -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 1-gen-2021 Vernieri, ClaudioNichetti, FedericoMarra, AntonioRandon, GiovanniLigorio, FrancescaFerraro, EmanuelaTrapani, DarioMilani, AndreaBernocchi, OttaviaAjazi, ArtaGenerali, DanieleLosurdo, AgneseCurigliano, GiuseppePruneri, GiancarloMariani, Luigide Braud, Filippo + Article (author) -
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs) 1-apr-2019 C. VernieriS. PuscedduG. FucàG. CentonzeL. CastagnoliE. FerrariA. AjaziS. CasolaM. FoianIV. MazzaferroG. PruneriF. de Braud + Article (author) -
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting 1-dic-2018 De Braud, F.Fucà, G.Pietrantonio, F.Vernieri, C.Di Nicola, M. + Article (author) -
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC 1-ago-2018 ZULATO, ELISABETTAF. de BraudC. Vernieri + Article (author) -
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. 1-gen-2018 S. PuscedduC. VernieriS. MassironiF. CavalcoliV. MazzaferroF. de Braud + Article (author) -
Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes 1-mag-2016 S. PuscedduC. VernieriV. MazzaferroF. De Braud + Article (author) -
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors 1-gen-2019 Fucà GGalli GImbimbo MTorri VColombo MPVernieri CBalsari Ade Braud F + Article (author) -
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer 1-giu-2018 C. VernieriA. MennittoM. PrisciandaroF. de Braud + Article (author) -
Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up 1-ago-2016 C. VernieriS. PuscedduF. De Braud + Article (author) -
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors 1-ago-2017 Pusceddu, SaraVernieri, ClaudioCORTI, FRANCESCADe Braud, Filippo + Article (author) -